Vcanbio Cell & Gene Engineering Corp., Ltd Stock
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.13 CNY | +1.38% | +3.20% | -20.42% |
Sales 2021 | 1.54B 212M | Sales 2022 | 1.55B 215M | Capitalization | 7.96B 1.1B |
---|---|---|---|---|---|
Net income 2021 | 155M 21.39M | Net income 2022 | 113M 15.6M | EV / Sales 2021 | 6.97 x |
Net cash position 2021 | 1.11B 154M | Net cash position 2022 | 1.25B 173M | EV / Sales 2022 | 4.31 x |
P/E ratio 2021 |
76.5
x | P/E ratio 2022 |
70.9
x | Employees | 2,332 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 72.17% |
1 day | +1.38% | ||
1 week | +3.20% | ||
Current month | -1.65% | ||
1 month | -4.39% | ||
3 months | -5.56% | ||
6 months | -12.62% | ||
Current year | -20.42% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 09-06-29 |
Xiao Ting Wang
DFI | Director of Finance/CFO | 42 | 22-05-24 |
Hai Bin Li
BRD | Director/Board Member | 53 | 16-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 09-06-29 |
Xin Yi Hou
BRD | Director/Board Member | 64 | 20-05-18 |
Hong Qi Wang
BRD | Director/Board Member | 59 | 23-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 16.13 | +1.38% | 3,420,213 |
24-04-23 | 15.91 | +1.73% | 3,544,628 |
24-04-22 | 15.64 | +1.43% | 4,008,999 |
24-04-19 | 15.42 | -0.90% | 2,871,144 |
24-04-18 | 15.56 | -0.45% | 4,608,400 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-20.42% | 1.04B | |
-0.80% | 12.72B | |
-11.57% | 7.5B | |
+2.40% | 5.48B | |
+0.98% | 4.61B | |
+5.18% | 4.47B | |
-50.82% | 3.28B | |
+11.23% | 2.71B | |
-17.93% | 2.02B | |
-10.84% | 1.74B |
- Stock Market
- Equities
- 600645 Stock